A collection of news and information related to Actos (drug) published by this site and its partners.
Displaying items 1-12 of 18 » View latimes.com items only1 2 Next >
Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...
Tags: Avandia (drug), Vioxx (drug), Laws, Justice System, Trials
From defective cars to dangerous drugs to hazardous roadways, the firm has represented thousands of clients in individual suits, class actions and mass torts over the past four decades. Robinson Calcagnie Robinson Shapiro Davis, Inc. specializes in...
By harnessing the power of lifestyle, the following people are managing their Type 2 diabetes without insulin, and in some cases without any medication at all. Some made the commitment when they were first diagnosed, but others reversed a condition that...
Booster ShotsSulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected......
If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...
If you take Lipitor, Actos, or Lexapro, new generics of these and other big-name drugs could be a real money saver. But are you saving as much as you should? Consumer Reports has discovered just because you're buying a generic drug doesn't mean you're...
Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...
AP Business WriterThe diabetes pill Avandia has been used by millions of patients and racked up billions in sales in more than a decade on the market. This week the Food and Drug Administration is trying to answer a seemingly simple question: Does it cause heart attacks?...
Mar 25, 2013 |Story| Los Angeles Times
Mar 26, 2012 |Story| Los Angeles Times
Nov 30, 2011 |Story| Los Angeles Times
Oct 26, 2009 |Story| Los Angeles Times
Dec 4, 2009 | Los Angeles Times
May 12, 2013 |Story| Herald Mail
Apr 15, 2013 |Story| WSBT-TV
Aug 1, 2012 |Story| Chicago Tribune
Feb 7, 2011 |Story| Reuters
Jul 13, 2010 |Story| Associated Press
Sep 27, 2010 |Story| Hola Hoy
Jun 24, 2010 |Story| Hola Hoy